Aastrom (ASTM) demonstrates statistical significance at 12 Months in RESTORE-CLI Clinical Trial
June 1st, 2011
No comments
RESTORE-CLI results met … primary safety and efficacy endpoints Read more…
Categories: Aastrom Biosciences, NASDAQ: ASTM, RESTORE-CLI trial
